Literature DB >> 18711743

Differential subcellular distribution and colocalization of the microsomal and soluble epoxide hydrolases in cultured neonatal rat brain cortical astrocytes.

Seema Rawal1, Christophe Morisseau, Bruce D Hammock, Amruthesh C Shivachar.   

Abstract

The microsomal epoxide hydrolase (mEH) and soluble epoxide hydrolase (sEH) enzymes exist in a variety of cells and tissues, including liver, kidney, and testis. However, very little is known about brain epoxide hydrolases. Here we report the expression, localization, and subcellular distribution of mEH and sEH in cultured neonatal rat cortical astrocytes by immunocytochemistry, subcellular fractionation, Western blotting, and radiometric enzyme assays. Our results showed a diffuse immunofluorescence pattern for mEH, which colocalized with the astroglial cytoskeletal marker glial fibrillary acidic protein (GFAP). The GFAP-positive cells also expressed sEH, which was localized mainly in the cytoplasm, especially in and around the nucleus. Western blot analyses revealed a distinct protein band with a molecular mass of approximately 50 kDa, the signal intensity of which increased about 1.5-fold in the microsomal fraction over the whole-cell lysate and other subcellular fractions. The polyclonal anti-human sEH rabbit serum recognized a protein band with a molecular mass similar to that of the affinity-purified sEH protein (approximately 62 kDa), the signal intensity of which increased over 1.7-fold in the 105,000g supernatant fraction over the cell lysate. Furthermore, the corresponding enzyme activities measured by using mEH- and sEH-selective substrates generally corroborated the immunocytochemical and Western blotting data. These results suggest that rat brain cortical astrocytes differentially coexpress mEH and sEH enzymes. The differential subcellular localization of mEH and sEH may play a role in the cerebrovascular functions that are known to be affected by brain-derived vasoactive epoxides. 2008 Wiley-Liss, Inc.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 18711743      PMCID: PMC3592782          DOI: 10.1002/jnr.21827

Source DB:  PubMed          Journal:  J Neurosci Res        ISSN: 0360-4012            Impact factor:   4.164


  39 in total

Review 1.  Epoxide hydrolases: mechanisms, inhibitor designs, and biological roles.

Authors:  Christophe Morisseau; Bruce D Hammock
Journal:  Annu Rev Pharmacol Toxicol       Date:  2005       Impact factor: 13.820

2.  Anti-inflammatory properties of cytochrome P450 epoxygenase-derived eicosanoids.

Authors:  K Node; Y Huo; X Ruan; B Yang; M Spiecker; K Ley; D C Zeldin; J K Liao
Journal:  Science       Date:  1999-08-20       Impact factor: 47.728

3.  Regional distribution and expression modulation of cytochrome P-450 and epoxide hydrolase mRNAs in the rat brain.

Authors:  B Schilter; C J Omiecinski
Journal:  Mol Pharmacol       Date:  1993-11       Impact factor: 4.436

Review 4.  Xenobiotic metabolism in brain.

Authors:  V Ravindranath; S Bhamre; S V Bhagwat; H K Anandatheerthavarada; S K Shankar; P S Tirumalai
Journal:  Toxicol Lett       Date:  1995-12       Impact factor: 4.372

Review 5.  Mammalian glutathione S-transferase: regulation of an enzyme system to achieve chemotherapeutic efficacy.

Authors:  A M Gulick; W E Fahl
Journal:  Pharmacol Ther       Date:  1995-05       Impact factor: 12.310

6.  Soluble epoxide hydrolase in rat inflammatory cells is indistinguishable from soluble epoxide hydrolase in rat liver.

Authors:  A J Draper; B D Hammock
Journal:  Toxicol Sci       Date:  1999-07       Impact factor: 4.849

7.  Improved radiolabeled substrates for soluble epoxide hydrolase.

Authors:  B Borhan; T Mebrahtu; S Nazarian; M J Kurth; B D Hammock
Journal:  Anal Biochem       Date:  1995-10-10       Impact factor: 3.365

8.  Soluble epoxide hydrolase is a main effector of angiotensin II-induced hypertension.

Authors:  Oliver Jung; Ralf P Brandes; In-Hae Kim; Frank Schweda; Ronald Schmidt; Bruce D Hammock; Rudi Busse; Ingrid Fleming
Journal:  Hypertension       Date:  2005-02-07       Impact factor: 10.190

9.  Effect of protein kinase C modulators on 14,15-epoxyeicosatrienoic acid incorporation into astroglial phospholipids.

Authors:  A C Shivachar; K A Willoughby; E F Ellis
Journal:  J Neurochem       Date:  1995-07       Impact factor: 5.372

10.  Metabolism of arachidonic acid to epoxyeicosatrienoic acids, hydroxyeicosatetraenoic acids, and prostaglandins in cultured rat hippocampal astrocytes.

Authors:  S C Amruthesh; M F Boerschel; J S McKinney; K A Willoughby; E F Ellis
Journal:  J Neurochem       Date:  1993-07       Impact factor: 5.372

View more
  16 in total

Review 1.  Discovery of inhibitors of soluble epoxide hydrolase: a target with multiple potential therapeutic indications.

Authors:  Hong C Shen; Bruce D Hammock
Journal:  J Med Chem       Date:  2012-01-17       Impact factor: 7.446

2.  Soluble epoxide hydrolase expression in a porcine model of arteriovenous graft stenosis and anti-inflammatory effects of a soluble epoxide hydrolase inhibitor.

Authors:  William G Sanders; Christophe Morisseau; Bruce D Hammock; Alfred K Cheung; Christi M Terry
Journal:  Am J Physiol Cell Physiol       Date:  2012-05-23       Impact factor: 4.249

Review 3.  Cytochrome P450 derived epoxidized fatty acids as a therapeutic tool against neuroinflammatory diseases.

Authors:  Jogen Atone; Karen Wagner; Kenji Hashimoto; Bruce D Hammock
Journal:  Prostaglandins Other Lipid Mediat       Date:  2019-11-05       Impact factor: 3.072

4.  Post-exposure administration of diazepam combined with soluble epoxide hydrolase inhibition stops seizures and modulates neuroinflammation in a murine model of acute TETS intoxication.

Authors:  Stephen T Vito; Adam T Austin; Christopher N Banks; Bora Inceoglu; Donald A Bruun; Dorota Zolkowska; Daniel J Tancredi; Michael A Rogawski; Bruce D Hammock; Pamela J Lein
Journal:  Toxicol Appl Pharmacol       Date:  2014-10-14       Impact factor: 4.219

5.  Anti-inflammatory treatment with a soluble epoxide hydrolase inhibitor attenuates seizures and epilepsy-associated depression in the LiCl-pilocarpine post-status epilepticus rat model.

Authors:  Yijun Shen; Weifeng Peng; Qinglan Chen; Bruce D Hammock; Junyan Liu; Dongyang Li; Jun Yang; Jing Ding; Xin Wang
Journal:  Brain Behav Immun       Date:  2019-07-12       Impact factor: 7.217

Review 6.  Cytochrome P450 epoxygenase pathway of polyunsaturated fatty acid metabolism.

Authors:  Arthur A Spector; Hee-Yong Kim
Journal:  Biochim Biophys Acta       Date:  2014-08-02

7.  Soluble epoxide hydrolase promotes astrocyte survival in retinopathy of prematurity.

Authors:  Jiong Hu; Sofia-Iris Bibli; Janina Wittig; Sven Zukunft; Jihong Lin; Hans-Peter Hammes; Rüdiger Popp; Ingrid Fleming
Journal:  J Clin Invest       Date:  2019-12-02       Impact factor: 14.808

Review 8.  Microsomal epoxide hydrolase 1 (EPHX1): Gene, structure, function, and role in human disease.

Authors:  Radka Václavíková; David J Hughes; Pavel Souček
Journal:  Gene       Date:  2015-07-26       Impact factor: 3.688

9.  Characterization of transgenic mice with neuron-specific expression of soluble epoxide hydrolase.

Authors:  Robert A Bianco; Khristofor Agassandian; Martin D Cassell; Arthur A Spector; Curt D Sigmund
Journal:  Brain Res       Date:  2009-07-28       Impact factor: 3.252

Review 10.  Epoxyeicosanoid signaling in CNS function and disease.

Authors:  Jeffrey J Iliff; Jia Jia; Jonathan Nelson; Toru Goyagi; Judy Klaus; Nabil J Alkayed
Journal:  Prostaglandins Other Lipid Mediat       Date:  2009-06-21       Impact factor: 3.072

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.